Skip to content
Just-Evotec Biologics
Just-Evotec BiologicsJust-Evotec Biologics
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec
Search:
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec

News & Insights

View allDDup 11PostersPress ReleasePublicationsScientific journalsTechnological insightsTrade journalsWebinarsWhite Papers & Application Notes

Just – Evotec Biologics to Collaborate with Ology Bioservices on Antibodies against Coronavirus

Press ReleaseApril 30, 2020

Partnership is part of a contract awarded to Ology Bioservices by the Department of Defense to develop and manufacture monoclonal antibodies for treatment and prevention…

Learn more

Designing Feature-Controlled Humanoid Antibody Discovery Libraries Using Generative Adversarial Networks

Publications, Scientific journalsApril 13, 2020

Just – Evotec Biologics has compiled a library of a new class of humanoid antibodies using a novel, AI-derived approach. Antibodies are proteins produced and…

Learn more

CoreAb Sequence Classification

White Papers & Application NotesMarch 12, 2020

A methodology has been developed for the structural alignment and classification of full sequences from antibodies and antibody-like structures using the Antibody Structural Numbering system…

Learn more

Just – Evotec Biologics Announces Product Development and Manufacturing Agreement With OncoResponse

Press ReleaseJanuary 16, 2020

Just – Evotec Biologics will apply its fully integrated technology platform in order to accelerate Oncoresponse’s lead product candidate through development and into the clinic

Learn more

Just – Evotec Biologics Initiates Construction of First J.POD® Facility in North America

Press ReleaseJanuary 14, 2020

The J.POD® technology expands Evotec’s capabilities into flexible commercial biologics manufacturing Confirms Evotec’s role as leading external innovator for the integrated outsourcing of drug discovery…

Learn more

Just – Evotec Biologics Enters Into Multi-Year Collaboration With MSD Around Facility of the Future

Press ReleaseJanuary 14, 2020

• MSD to gain access to manufacturing know-how within Just – Evotec Biologics’ J.POD® facility (“Facility of the future”) • Multi-year collaboration in form of…

Learn more

Framework Mutations of the 10-1074 bnAb Increase Conformational Stability, Manufacturability, and Stability While Preserving Full Neutralization Activity

Publications, Scientific journalsJanuary 1, 2020

Journal of Pharmaceutical Sciences

Learn more

Shocking Data on Parcel Shipments of Protein Solutions

Publications, Scientific journalsNovember 2, 2019

Journal of Pharmaceutical Sciences

Learn more

Just – Evotec Biologics & Biocon Biologics sign licensing deal for a biosimilar asset

Press ReleaseOctober 19, 2019

Biocon Biologics in-licenses an early-stage biosimilar asset, will undertake development, manufacturing and commercialisation under its own label. Just – Evotec Biologics has received a license…

Learn more

Limiting the metabolic burden of recombinant protein expression during selection yields pools with higher expression levels

Publications, Scientific journalsSeptember 15, 2019

Biotechnology Progress

Learn more

Evotec completes acquisition of Just Biotherapeutics

Press ReleaseJuly 3, 2019

Acquisition extends Evotec’s multimodality offering, with integrated solutions for small molecules and biologics. Expands Evotec’s US footprint in Seattle and machine learning capabilities. Deal value…

Learn more

Just Biotherapeutics and Teva enter an agreement for the design and development of a high productivity (HP) biomanufacturing process

Press ReleaseJune 28, 2019

Just Biotherapeutics, Inc. (“Just.Bio”), an integrated design company focused on technologies for accelerating the development and manufacture of biotherapeutics, announced today that they have entered…

Learn more
←12345→
innovation by design
North America
Just – Evotec Biologics, Inc.
401 Terry Avenue
Seattle, WA 98109
+1 206-651-5094
Europe + International
Just – Evotec Biologics
Business Development
info@evotec.com

Find us on:

Twitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
© 2023 Just – Evotec Biologics
  • Contact
  • Imprint
  • Privacy Policy
  • Legal notice
footer menu
Go to Top
  • Ask an expert
  • Tweet
  • Share
  • Email
  • Scroll to top
  • Ask an expert
  • Twitter
  • Linkedin
  • Email
  • Whatsapp